Beta-blockers to reduce mortality in patients with systolic dysfunction: A meta-analysis

Journal of Family Practice

Volumn 50, Issue 6, 2001, Pages 499-504

  Lee, S ^a   Spencer, A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adrenergic beta antagonist; Cardiomyopathy, congestive; Heart failure, congestive

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BISOPROLOL; CARVEDILOL; METOPROLOL; PLACEBO;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; DOSE RESPONSE; DRUG TOLERANCE; HEART DEATH; HEART FAILURE; HUMAN; INOTROPISM; META ANALYSIS; MORTALITY; OUTCOMES RESEARCH; STATISTICAL ANALYSIS; SUDDEN DEATH; SYSTOLE;

ADRENERGIC BETA-ANTAGONISTS; BISOPROLOL; CARBAZOLES; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; METOPROLOL; PROPANOLAMINES; RESEARCH DESIGN; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYSTOLE; TREATMENT OUTCOME;

EID: 0034974810     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Consensus, recommendations for the management of chronic heart failure
2. Beta-blockers in heart failure: Promising or proved?
3. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF)
4. Betaxolol versus carvedilol in chronic heart failure (BETACAR study) rationale and design
5. Mechanism of action of beta-blocking agents in heart failure
6. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure
7. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
8. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure
9. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
10. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and β-blockers in patients with congestive heart failure: Design of the randomized evaluation of strategies for left ventricular dysfunction (RESOLVED) Pilot Study
11. A randomized trial of (-blockade in heart failure: The cardiac insufficiency bisoprolol study (CIBIS)
12. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial
13. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
14. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
15. Design of the beta-blocker evaluation survival trial (BEST)
16. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
17. Carvedilol
18. Arrhythmias and mortality in congestive heart failure
19. Randomised trial of low-dose amiodarone in severe congestive heart failure
20. Experience with beta-blockers in heart failure mortality trials
21. β-Blockers in heart failure: The 'new wave' of clinical trials